Canada markets closed

Windtree Therapeutics, Inc. (WINT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4215+0.0015 (+0.36%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.90M
Enterprise Value -1.31M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)660.53
Price/Book (mrq)0.52
Enterprise Value/Revenue 706.08
Enterprise Value/EBITDA 0.05

Trading Information

Stock Price History

Beta (5Y Monthly) 0.59
52-Week Change 3-93.69%
S&P500 52-Week Change 321.83%
52 Week High 311.9800
52 Week Low 30.2800
50-Day Moving Average 30.3694
200-Day Moving Average 30.8605

Share Statistics

Avg Vol (3 month) 3270.08k
Avg Vol (10 day) 3232.99k
Shares Outstanding 59.18M
Implied Shares Outstanding 69.41M
Float 84.55M
% Held by Insiders 14.65%
% Held by Institutions 112.91%
Shares Short (Mar 28, 2024) 439.65k
Short Ratio (Mar 28, 2024) 40.62
Short % of Float (Mar 28, 2024) 40.43%
Short % of Shares Outstanding (Mar 28, 2024) 40.43%
Shares Short (prior month Feb 29, 2024) 458.41k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 29, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Feb 24, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.23%
Return on Equity (ttm)-199.40%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.55M
Net Income Avi to Common (ttm)-24.83M
Diluted EPS (ttm)-16.7900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.37M
Total Cash Per Share (mrq)1.43
Total Debt (mrq)17.16M
Total Debt/Equity (mrq)229.25%
Current Ratio (mrq)2.40
Book Value Per Share (mrq)1.45

Cash Flow Statement

Operating Cash Flow (ttm)-13.25M
Levered Free Cash Flow (ttm)-8.02M